KIAA1609 Antikörper (C-Term)
Kurzübersicht für KIAA1609 Antikörper (C-Term) (ABIN7845469)
Target
Alle KIAA1609 (MEAK7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Rabbit polyclonal antibody to TLDC1
-
Spezifität
- Recognizes endogenous levels of TLDC1 protein.
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human TLDC1. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/1000 - 1/2000), IH (1/50 - 1/200), FC (1/10 - 1/50)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- KIAA1609 (MEAK7) (MTOR associated protein, eak-7 homolog (MEAK7))
-
Andere Bezeichnung
- TLDC1
-
Hintergrund
- KIAA1609, TLD domain-containing protein 1, TBC/LysM-associated domain-containing protein 1
-
Gen-ID
- 57707, 74347
-
UniProt
- Q6P9B6
Target
-